The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: Results of a multicentre open-label study

1. Santos-Gómez, M.
2. Calvo-Río, V.
3. Blanco, R.
4. Beltrán, E.
5. Mesquida, M.
6. Adán, A.
7. Cordero-Coma, M.
8. García-Aparicio, Á.M.
9. Pascual, E.V.
10. Martínez-Costa, L.
11. Hernández, M.V.
12. Garfella, M.H.
13. González-Vela, M.C.
14. Pina, T.
15. Palmou-Fontana, N.
16. Loricera, J.
17. Hernández, J.L.
18. González-Gay, M.A.